Avner Lushi - 15 Aug 2024 Form 3 Insider Report for Biomotion Sciences (SLXN)

Role: Director, 10%+ Owner
Signature: /s/ Mirit Horenshtein-Hadar, as attorney for Avner Lushi
Issuer symbol: SLXN
Transactions as of: 15 Aug 2024
Net transactions value: $0
Form type: 3
Filing time: 15 Aug 2024, 19:38:56 UTC
Next filing: 31 Dec 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SLXN	Ordinary Shares						1,987,083	15 Aug 2024	By Guangzhou Sino-Israel Biotech Fund	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person possesses shared voting and investment authority with respect to the shares reported in this line as a result of his serving as a Managing Partner and CEO of Guangzhou Sino-Israel Biotech Fund ("GIBF"). The equity interests of GIBF are held by various individuals and entities. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his indirect pecuniary interest therein.

Content

The Reporting Person possesses shared voting and investment authority with respect to the shares reported in this line as a result of his serving as a Managing Partner and CEO of Guangzhou Sino-Israel Biotech Fund ("GIBF"). The equity interests of GIBF are held by various individuals and entities. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his indirect pecuniary interest therein.

Remarks:

Exhibit 24.1 Power of Attorney